Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis (2024)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jtha.2023.11.009
Publication URI: http://dx.doi.org/10.1016/j.jtha.2023.11.009
Type: Journal Article/Review
Parent Publication: Journal of Thrombosis and Haemostasis
Issue: 3